×

Devices, systems and methods for evaluation of hemostasis

  • US 10,481,168 B2
  • Filed: 02/26/2018
  • Issued: 11/19/2019
  • Est. Priority Date: 02/15/2011
  • Status: Active Grant
First Claim
Patent Images

1. An apparatus configured as a disposable cartridge, the apparatus comprising:

  • a housing;

    a plurality of test chambers located in the housing, the plurality of test chambers including chambers configured for viscoelastic measurements via a system that interrogates one or more viscoelastic properties of test samples in the test chambers, wherein the one or more viscoelastic properties is used to characterize dynamics of coagulation and/or fibrinolysis including clot stiffness of a clot formed in the test samples, wherein the plurality of test chambers comprise a first test chamber and a second test chamber each defined by a space sufficient to allow induced displacement of the test sample in the test chamber from an application of a force applied to the test sample when the system interrogates the one or more viscoelastic properties of the test sample; and

    a fluid pathway comprising a plurality of channels, each defined at least in part by the housing, wherein the fluid pathway includes an inlet, defined at least in part by the housing, through which a blood sample is introduced into the apparatus, wherein at least one channel of the fluid pathway is in communication with the inlet and with the first test chamber and a second test chamber to deliver a portion of the blood sample to each of the first test chamber and the second test chamber, wherein the at least one channel of the fluid pathway includes an inlet channel, a first channel, and a second channel, wherein the inlet channel is in communication with the inlet, and wherein the first channel is in communication with the inlet channel and at least with the first test chamber, and wherein the second channel is in communication with the inlet channel and at least with the second test chamber;

    a first reagent or a first combination of reagents configured to activate coagulation, wherein the first reagent or the first combination of reagents is preloaded in a first space associated with the first test chamber for a single use in the disposable cartridge, and wherein the first reagent or the first combination of reagents interacts with a portion of the blood sample drawn through the first channel to form a first test sample, wherein the first test sample can be interrogated in the first test chamber to provide a first viscoelastic measurement that provides a determination of one or more clot stiffness values of a first clot formed in the first test sample in which the first clot is formed without platelet aggregation being inhibited, wherein the first reagent or the first combination of reagents comprises abciximab; and

    a second combination of reagents comprising i) a reagent, or a combination of reagents, configured to activate coagulation and ii) a reagent, or a combination of reagents, to inhibit platelet aggregation, wherein the second combination of reagents is preloaded in a second space associated with the second test chamber for a single use in the disposable cartridge, and wherein the second combination of reagents interacts with a portion of the blood sample drawn through the second channel to form a second test sample, wherein the second test sample can be interrogated in the second test chamber to provide a second viscoelastic measurement that provides a determination of one or more clot stiffness values of a second clot formed in the second test sample in which the second clot is formed with platelet aggregation being inhibited.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×